Taro Pharmaceutical
TARO
#5309
Rank
A$2.34 B
Marketcap
A$62.34
Share price
0.00%
Change (1 day)
1.99%
Change (1 year)

EPS for Taro Pharmaceutical (TARO)

EPS in 2023 (TTM): A$0.92

According to Taro Pharmaceutical's latest financial reports the company's current EPS (TTM) is A$1.77. In 2021 the company made an earnings per share (EPS) of A$0.05803 an increase over its 2020 EPS that were of A-$11.48.

EPS history for Taro Pharmaceutical from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)A$0.92
2021A$0.05803-100.51%
2020A-$11.48-222.45%
2019A$9.37-18.02%
2018A$11.4353.01%
2017A$7.47-55.95%
2016A$16.96-13.41%
2015A$19.5936.92%
2014A$14.3037.71%
2013A$10.3921.15%
2012A$8.5744.15%
2011A$5.95175.17%
2010A$2.16-48.8%
2009A$4.22
2005A$0.04352-91.89%
2004A$0.54-82.55%
2003A$3.0835.9%
2002A$2.2639.29%
2001A$1.62140.86%
2000A$0.6769.09%
1999A$0.40139.13%
1998A$0.1764.29%
1997A$0.10-36.36%
1996A$0.16

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$9.70 447.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$7.62 330.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.10-37.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$1.44-18.63%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$4.17 135.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$0.91-48.36%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel